Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.’s Net Profit Rose 28.8% in 2022
Listen to the full version

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (浙江莎普爱思药业股份有限公司) (603168.SH) reported a net profit of 45.9 million yuan in 2022, up 28.8% year-on-year.
Meanwhile, the company posted 549.5 million yuan in revenue, down 12.7% year-on-year.
At the end of the reporting period, it had 2 billion yuan in total assets and 241 million yuan in total liabilities, with a liability-to-asset ratio of 12.3%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR